Literature DB >> 24842823

Early recurrence of active IgA nephropathy after kidney transplantation.

Yasuhiro Otsuka1, Asami Takeda, Keiji Horike, Daijyo Inaguma, Norihiko Goto, Yoshihiko Watarai, Kunio Morozumi.   

Abstract

IgA nephropathy (IgAN) is recurrent after transplantation; however, its time of recurrence is unpredictable. To date, factors influencing IgAN recurrence have not been elucidated. We present a case of a 23-year-old man with end-stage renal disease (ESRD) who underwent living-related ABO-identical pre-emptive kidney transplantation (PEKT) using his 57-year-old mother as a donor. IgAN started when the patient was 19 years old, and renal biopsy revealed the usual pathological findings of IgAN. In spite of steroid therapy including steroid pulse and tonsillectomy, the patient developed nephrotic syndrome and progressed to ESRD in 4 years. Protocol biopsy on day 19 following PEKT revealed active recurrent IgAN. Nephrotic-range proteinuria and mild deterioration of kidney function developed regardless of strong immunosuppressive therapy such as steroid pulse, double filtration plasmapheresis and rituximab. We report a case of refractory IgAN that recurred 19 days after transplantation. This case is considered of value to elucidate factors leading to active IgAN recurrence.
© 2014 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  IgA nephropathy; early recurrence; recurrent IgA nephropathy; recurrent glomerulonephritis; renal transplantation

Mesh:

Substances:

Year:  2014        PMID: 24842823     DOI: 10.1111/nep.12252

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  3 in total

1.  Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; T Kahn; J Fahnert
Journal:  Clin Exp Immunol       Date:  2015-11-26       Impact factor: 4.330

Review 2.  Kidney retransplantation in children following rejection and recurrent disease.

Authors:  Rebecca C Graves; Richard N Fine
Journal:  Pediatr Nephrol       Date:  2016-04-05       Impact factor: 3.714

3.  CDR3 sequences in IgA nephropathy are shorter and exhibit reduced diversity.

Authors:  Xi Zhang; Jianming Zeng; Yin Tong; Li Zhang; Xibin Lu; Shenglang Zhu; Zhoufang Li
Journal:  FEBS Open Bio       Date:  2020-11-20       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.